Composition for predicting clinical stage of Alzheimer's disease and kit using the same

摘要

Of the present invention Nos1 (Nitric oxide synthase 1), Aph1B (Anterior pharynx defective 1 homolog B), Ryr3 (Ryanodine receptor 3), Atf6 (Activating transcriptional factor 6), Ip3r (Inositol trisphosphate receptor), Nep (Neprilysin), Cdk5 ( cyclin dependent kinase 5) and Abad (Amyloid beta-binding alcohol dehydrogenase) composition for predicting Alzheimer's prognosis containing a detection reagent that specifically binds to any one or more genes selected from the group consisting of, kits and prognosis information The provided method can rapidly and accurately predict the prognosis of Alzheimer's disease, and can determine the prognosis for the drug by comparing the expression level before and after drug administration, so that an appropriate treatment direction can be determined according to the predicted prognosis. Therefore, there is an effect that can greatly contribute to the reduction of mortality due to Alzheimer's.